Grading of ovarian cancer: a histotype-specific approach.
Over the last decade, our understanding of ovarian cancer has evolved; it is no longer considered a single entity, but instead a heterogeneous group of tumors. Accordingly, a histotype-specific grading system seems to be more appropriate than a universal grading system to reflect the diversity of this disease. In this article, this histotype-specific approach to the grading of ovarian carcinoma is discussed.
Malpica
Anais
A
Department of Pathology, The University of Texas M.D. Anderson Cancer, Houston, Texas 77030, USA. amalpica@mdanderson.org
D018262:Adenocarcinoma, Clear Cell / Q000175:diagnosis / Q000473:pathology; D002277:Carcinoma / Q000175:diagnosis / Q000473:pathology; D002295:Carcinoma, Transitional Cell / Q000175:diagnosis / Q000473:pathology; D003937:Diagnosis, Differential; D005260:Female; D006801:Humans; D009367:Neoplasm Staging / Q000379:methods*; D018297:Neoplasms, Cystic, Mucinous, and Serous / Q000175:diagnosis / Q000473:pathology; D010051:Ovarian Neoplasms / Q000175:diagnosis* / Q000473:pathology*; D011379:Prognosis